These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20358387)

  • 1. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
    Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
    Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
    Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
    Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.
    Upadhyaya M; Spurlock G; Kluwe L; Chuzhanova N; Bennett E; Thomas N; Guha A; Mautner V
    Neurogenetics; 2009 Jul; 10(3):251-63. PubMed ID: 19221814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
    Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
    Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
    Thomas L; Mautner VF; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Sep; 6(1):18. PubMed ID: 23244685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients.
    De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E
    Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
    Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
    Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.
    Birindelli S; Perrone F; Oggionni M; Lavarino C; Pasini B; Vergani B; Ranzani GN; Pierotti MA; Pilotti S
    Lab Invest; 2001 Jun; 81(6):833-44. PubMed ID: 11406645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.
    Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
    Kluwe L; Friedrich RE; Mautner VF
    Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
    Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
    Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
    Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
    Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
    Eisenbarth I; Beyer K; Krone W; Assum G
    Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chaney KE; Perrino MR; Kershner LJ; Patel AV; Wu J; Choi K; Rizvi TA; Dombi E; Szabo S; Largaespada DA; Ratner N
    Cancer Res; 2020 Nov; 80(21):4720-4730. PubMed ID: 32816910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
    Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
    Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.